Ucb Biopharma Srl
Clinical trials sponsored by Ucb Biopharma Srl, explained in plain language.
-
New drug shows promise for rare eye muscle disease in Long-Term trial
Disease control Not yet recruitingThis study looks at the long-term safety and effectiveness of a drug called rozanolixizumab for adults with ocular myasthenia gravis, a condition that causes muscle weakness in the eyes. About 100 people who have already taken the drug in a previous study will continue treatment.…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New study aims to map rare childhood brain disorder
Knowledge-focused Not yet recruitingThis study will follow 60 children with SLC6A1-NDD, a rare genetic condition causing seizures, developmental delays, and autism. Researchers will track symptoms like seizure frequency and development over time to better understand the disease. The goal is to gather information th…
Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC